Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (42)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Farrell, D. J.
Right arrow Articles by Felmingham, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrell, D. J.
Right arrow Articles by Felmingham, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 541-544
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization

D. J. Farrell*,, I. Morrissey, S. Bakker and D. Felmingham

GR Micro Limited, 7–9 William Road, London NW1 3ER, UK

In this study, a multiplex rapid cycle PCR with microwell-format probe hybridization method was developed to perform high-volume screening for macrolide resistance determinants in isolates of Streptococcus pneumoniae and Streptococcus pyogenes. The method was then utilized to determine the distribution of macrolide resistance mechanisms in recent isolates of S. pneumoniae and S. pyogenes from Great Britain and Ireland. For 83 strains of macrolide resistant S. pneumoniae tested, 51 (61.4%) were positive for mef(A), 29 (34.9%) erm(B), two (2.4%) double mechanisms mef(A) + erm(B), and one (1.2%) negative for all mechanisms tested. For 56 strains of macrolide-resistant S. pyogenes tested, 33 (58.9%) were positive for erm(A) subclass erm(TR), 18 (32.1%) mef(A) and five (8.9%) erm(B).

* Corresponding aurthor: Tel: +44-20-7388-7320; Fax: +44-20-7388-7324; E-mail: d.farrell{at}grmicro.co.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. Blackman Northwood, M. Del Grosso, L. R. Cossins, M. D. Coley, R. Creti, A. Pantosti, and D. J. Farrell
Characterization of Macrolide Efflux Pump mef Subclasses Detected in Clinical Isolates of Streptococcus pyogenes Isolated between 1999 and 2005
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1921 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
D. J. Farrell, T. M. File, and S. G. Jenkins
Prevalence and Antibacterial Susceptibility of mef(A)-Positive Macrolide-Resistant Streptococcus pneumoniae over 4 Years (2000 to 2004) of the PROTEKT US Study
J. Clin. Microbiol., February 1, 2007; 45(2): 290 - 293.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
X. Zeng, F. Kong, H. Wang, A. Darbar, and G. L. Gilbert
Simultaneous Detection of Nine Antibiotic Resistance-Related Genes in Streptococcus agalactiae Using Multiplex PCR and Reverse Line Blot Hybridization Assay
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L. Davignon, E. A. Walter, K. M. Mueller, C. P. Barrozo, D. A. Stenger, B. Lin, and on behalf of the Epidemic Outbreak Surveillance Co
Use of Resequencing Oligonucleotide Microarrays for Identification of Streptococcus pyogenes and Associated Antibiotic Resistance Determinants
J. Clin. Microbiol., November 1, 2005; 43(11): 5690 - 5695.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. F. N. Twagira, J. J. Wade, I. Eltringham, and M. Smith
Development of a real-time PCR assay on the Roche Light-Cycler for the detection of erm and mef erythromycin resistance genes in {beta}-haemolytic streptococci
J. Antimicrob. Chemother., October 1, 2005; 56(4): 793 - 794.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. H. W. Klaassen and J. W. Mouton
Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E)
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. D. Brown, D. J. Farrell, and I. Morrissey
Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study
J. Clin. Microbiol., November 1, 2004; 42(11): 4980 - 4987.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
D J Farrell, S G Jenkins, and R R Reinert
Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators
J. Med. Microbiol., November 1, 2004; 53(11): 1109 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. J. Farrell, I. Morrissey, S. Bakker, S. Buckridge, and D. Felmingham
In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3169 - 3171.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Villedieu, M. L. Diaz-Torres, A. P. Roberts, N. Hunt, R. McNab, D. A. Spratt, M. Wilson, and P. Mullany
Genetic Basis of Erythromycin Resistance in Oral Bacteria
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2298 - 2301.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
D. J. Farrell, I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham
Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance
J. Clin. Microbiol., February 1, 2004; 42(2): 764 - 768.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. N. Jones, D. J. Farrell, and I. Morrissey
Quinupristin-Dalfopristin Resistance in Streptococcus pneumoniae: Novel L22 Ribosomal Protein Mutation in Two Clinical Isolates from the SENTRY Antimicrobial Surveillance Program
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2696 - 2698.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. J. Farrell, S. Douthwaite, I. Morrissey, S. Bakker, J. Poehlsgaard, L. Jakobsen, and D. Felmingham
Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study
Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1777 - 1783.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Zampaloni, P. Cappelletti, M. Prenna, L. A. Vitali, and S. Ripa
emm Gene Distribution among Erythromycin-Resistant and -Susceptible Italian Isolates of Streptococcus pyogenes
J. Clin. Microbiol., March 1, 2003; 41(3): 1307 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Liu and S. Douthwaite
Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy
PNAS, November 12, 2002; 99(23): 14658 - 14663.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.